Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids
|
February 15, 2024
Drops on Polymer Brushes: Advances in Thin-Film Modeling of Adaptive Substrates
Simon Hartmann, Jan Diekmann, Daniel Greve, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 20, 2007
Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response
Eleni Adamopoulou, Jan Diekmann, Eva Tolosa, et al.
Cancer Immunology Research
|
April 30, 2014
mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA
Mustafa Diken, Sebastian Kreiter, Fulvia Vascotto, et al.
Cancer Research
|
August 6, 2011
FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines
Sebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 10, 2009
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement
Jan Diekmann, Eleni Adamopoulou, Olaf Beck, et al.
Vaccines
|
February 28, 2023
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
Cynthia M Rohde, Claudia Lindemann, Michael Giovanelli, et al.
Nature Immunology
|
June 12, 2026
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models
Neha Agrawal, Louis S Ates, Stefan A Schille, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
May 31, 2021
Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine
Christopher J Bowman, Marie Bouressam, Sarah N Campion, et al.
Nature
|
April 23, 2015
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer, et al.
Cancer Research
|
January 13, 2012
Exploiting the mutanome for tumor vaccination
John C Castle, Sebastian Kreiter, Jan Diekmann, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Langmuir : the ACS Journal of Surfaces and Colloids
|
February 15, 2024
Drops on Polymer Brushes: Advances in Thin-Film Modeling of Adaptive Substrates
Simon Hartmann, Jan Diekmann, Daniel Greve, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 20, 2007
Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response
Eleni Adamopoulou, Jan Diekmann, Eva Tolosa, et al.
Cancer Immunology Research
|
April 30, 2014
mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA
Mustafa Diken, Sebastian Kreiter, Fulvia Vascotto, et al.
Cancer Research
|
August 6, 2011
FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines
Sebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 10, 2009
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement
Jan Diekmann, Eleni Adamopoulou, Olaf Beck, et al.
Vaccines
|
February 28, 2023
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
Cynthia M Rohde, Claudia Lindemann, Michael Giovanelli, et al.
Nature Immunology
|
June 12, 2026
mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models
Neha Agrawal, Louis S Ates, Stefan A Schille, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
May 31, 2021
Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine
Christopher J Bowman, Marie Bouressam, Sarah N Campion, et al.
Nature
|
April 23, 2015
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer, et al.
Cancer Research
|
January 13, 2012
Exploiting the mutanome for tumor vaccination
John C Castle, Sebastian Kreiter, Jan Diekmann, et al.
Page
of 2